INTRODUCTION
Disseminated gonococcal infection (DGI),1 usually associated with arthritis and dermatitis occurs in an estimated 1-3% of patients with gonorrhea in Seattle, Wash. (1) . Most strains recovered from patients with disseminated disease in Seattle are susceptible to .0.030 ,ug/ml of penicillin G (2) and require arginine, hypoxanthine, and uracil for growth (3) . In contrast, strains that produce localized gonococcal infection are usually more resistant to penicillin and are of varying auxotypes (3). These differences suggest that strains which cause DGI are unique and might possess virulence factor(s) that mediate dissemination.
Virulence and resistance to the complement-dependent bactericidal activity of normal human serum appear to be closely associated for many gram-negative bacteria (4-9). Glynn and Ward showed that some strains of gonococci were resistant to the bactericidal action of normal human sera (10), but did not relate this property to virulence. Spink and Keefer reported in 1937 that fresh defibrinated blood from healthy men killed gonococci isolated from uncomplicated genital infections more efficiently than systemic gonococcal isolates (11) . The present study extends the observations of Spink and Keefer and examines the * Auxotype: Arg-Hyx-Ura-, requires arginine, hypoxanthine, and uracil for growth; Proto, prototrophic for proline, arginine, hypoxanthine, uracil, and methionine; Pro-, proline requiring; Arg-, arginine requiring.
t Pen. MIC, Minimum inhibitory concentration of penicillin G, expressed in micrograms per milliliter. § Isolation site: Systemic, blood, joint effusion, or skin pustule; Local, urethra, cervix, or anal canal. 1 I Serum source: Individual, strain tested individually with 20 normal human sera for serum susceptibility; Pool, strain tested with pooled normal human sera for serum susceptibility; Acute/Conv, strain tested with acute and convalescent sera from six patients with DGI. Numbers exceed total number ofstrains because some strains were tested by more than one serum source.
relationship of auxotype and penicillin sensitivity to the resistance of gonococci to the bactericidal action of normal human sera.
METHODS

Bacteriological techniques
Selection, identification, and storage of organisms tested. Strains of Neisseria gonorrhoeae used in this study included strains F62 and 9, supplied by Dr. Douglas Kellogg, Center for Disease Control, Atlanta, Ga., 39 isolates from Seattle patients with DGI, and 41 isolates from Seattle patients with uncomplicated gonorrhea (Table I ). The 39 isolates from patients with DGI included 14 recovered from blood, synovial effusion, or a skin pustule, and 25 recovered from the urethra or cervix of patients with typical manifestations of the gonococcal arthritis-dermatitis syndrome (1) . The 41 strains of gonococci from patients with uncomplicated gonorrhea were isolated on Thayer-Martin medium (12) from urethra, endocervix, or anal canal. All Seattle strains were isolated during 1971-1975. Isolates were identified as N. gonorrhoeae by oxidase reaction, Gram stain, and sugar fermentation reactions (13) and preserved by lyophilization (14) or freezing at -70°C in a medium consisting of 5% (wt/vol) bovine serum albumin (Armour Pharmaceutical Co., Chicago, Ill.) and 5% (wt/vol) monosodium glutamate (15) . All clinical isolates were tested in the bactericidal assay after the fewest in vitro passes required for isolation in pure culture and confirmation of species and were maintained as colony variants Ti or T2 (16, 17) , except for strain 1947 which was tested as colony variant T3. In addition, eight of the genital isolates were tested after 1 and 10 in vitro passes to assess the effect of subculturing on their susceptibility to the bactericidal action of serum. Strains F62 and 9 were laboratory strains which had been passed multiple times in vitro before bactericidal testing.
Auxotyping and penicillin susceptibility testing. Gonococci were auxotyped by the method of Catlin (18) and Carifo and Catlin (19) as modified by Knapp and Holmes (3) , and their susceptibility to penicillin G (Table I) was determined as the minimum inhibitory concentration (MIC) by an agar dilution technique, using serial log2 dilutions of penicillin G in GC base medium (Difco Laboratories, Detroit, Mich.) with the addition of 1% defined supplement (20) . The suspension of organisms was adjusted to an optical density of 0.15 (560 nm, 1 cm lightpath) in a Spectronic 20 Colorimeter (Bausch & Lomb, Inc., Scientific Optical Products Div., Rochester, N. Y.) and was inoculated using a Steers replicator (21) .
10 strains were assessed at the time of isolation and after 6 and 12 mo of storage for stability of auxotype and penicillin MIC. Their nutritional profiles were unchanged during the period of study and their susceptibility to penicillin varied within a single log2 dilution. No change in the requirement of 13 strains of arginine, hypoxanthine, and uracil was observed after 4-10 in vitro passages.
Preparation of bacterial suspensions for use in the bactericidal assay. All comparisons between strains of their susceptibility to the bactericidal action of normal human sera were made with organisms grown in identical media with bacterial suspensions prepared in a standardized manner. Specifically, all strains of each auxotype were harvested with a sterile swab from 18-h cultures on GC agar medium containing 1% defined supplement, suspended in Tryptic Soy Broth (Difco Laboratories) to an optical density of 0.10 at 560 nm, and 100 ,ul was inoculated onto GC base medium containing defined supplement. Plates were incubated at 36.50C in 3% CO2 and were harvested by washing the plates with Tryptic Soy Broth after 5 h of incubation. These strains were determined, by serial replicate plate counts of viable organisms, to be in early log phase growth 5 h after inoculation of agar.
Individual strains tested for change in serum susceptibility after 1 and 10 in vitro passes (strains 1 through 8 of Table  III) and with acute and convalescent sera (strains F62 and  6366 of Table VI) Mass.) and frozen in 2-ml aliquots at -20°and -70°C. Serum was heat inactivated at 560C for 30 min before use in the bactericidal assay.
Sera from six patients with DGI (Table I) were obtained immediately before the initiation of antibiotic therapy and again at varying intervals after antibiotics had been discontinued. In addition, acute sera obtained from 18 patients presenting with gonococcal arthritis were tested for complement activity.
Complement
Fresh sera from many species, including newborn guinea pigs, adolescent rabbits, and adult humans, proved unsatisfactory as sources of complement, because all such sera were bactericidal for many strains of N. gonorrhoeae. The source of complement for the bactericidal test was a 25-yr-old Caucasian man with X-linked agammaglobulinemia (23) (24) whose serum lacked bactericidal activity for all strains of N. gonorrhoeae tested but supported the bactericidal action of heat-inactivated normal human sera for serum-sensitive strains. Serum obtained just before the donor's monthly gamma globulin infusion was stored at -70°C. The concentration of immunoglobulins in this serum, expressed in milligrams per 100 milliliters, was determined by quantitative radial immunodiffusion (Behring Diagnostics, American Hoechst Corp., Somerville, N. J.) to be: IgG < 199 , to give a final complement activity >20 CH50 U/mIl of reaction mixture. The sera were doubly diluted from 1:2 through 1:16,384, and each dilution was performed in triplicate for each strain tested. Complement controls (without added serum) and heat-inactivated serum controls (without added complement) were included in each experimenit. The trays were sealed with sterile transparent tape (Cooke Laboratory Products Div.), shaken horizontally to mix the reactants, and incubated at 36.5°C on a gyratory shaker for 60 min. Sterile Pasteur pipettes were then used to deliver a drop of fluid from each well onto dried, warmed GC base medium with added supplement. The plates were inlCubated for 18 h at 36.5°C in the presence of 3% CO} anid moisture. The pipettes delivered approximately 50 ,ul/drop, and in the absence of bactericidal activity suich a drop contained approximately 200 CFUs.
Agglutination ("clumping") of gonlococcal colony varianlts Ti and T2 in liquid media was diminished by vortex agitation of the bacterial suspension and use of a low conicentration of organisms in the bactericidal assay. Both ain electronic particle counter study (Model ZH Couilter Couniiter, Coulter Electronics Inc., Hialeah, Fla.) aind observation by dark-field microscopy determined that the frequency distribution of bacterial aggregates (and organismiis per aggregate) was equal for the seruni and complemenit controls, the serum titers at which greater thani a 75% reductioni in CFUs occurred (significant killing), aind serulm titers at which no reduction in CFUs was noted.
Kinetic killing experimenits
The rate of the complement-depenident bactericidal action of normal human sera was studied for four strainis from patients with disseminated inifectioni anid four from patients with uncomplicated inifectioni. Undiluited pooled serum stored at -700C was added in 50-Al amouniits to each microtiter well, and approxim-ately 1,000 CFUs in log phase growth were added in 5-,ul volume to each well. At predetermined time intervals over a 90-miml period, 200 ,A of Medium 199 was added, aind the well conitents were cultured immediately as described above. Heatinactivated serum and buffer conitrols were ctultured conicurrently.
Interpretation of bactericidal test
Significant bactericidal activity was defined as a 75% r-eduction in CFUs when compared witlh the heat-inactivated serum control. The bactericidal titer was definied as the reciprocal of the greatest dilutioni of serumiii producinig significant killing. In kinetic killing experimenits, the rate of the bactericidal reaction was characterized by the percentage of surviving bacteria at each saimplinig time interval when compared to the concurrently sacmpled heat-iniactivated serum controls.
RESULTS
Bactericidal titer of ntiormial sera for gonlococci recovered fromu patients Wcitli uiretilm-al, cerrvical, or disseinaiti(ted infectioni. Normal humani sera from 20
Gotnococci Cauisin£g Disseminated Infection are Serum Resistant healthy men and women without a history of gonorrhea were bactericidal (serum titer 2 2) for each of five strains of gonococci isolated from patients with uncomplicated urethral or cervical infections. These included two laboratory-adapted strains (F62 and 9) and three recent isolates (Table II) . None of these strains required arginine, hypoxanthine, or uracil for growth. As shown in Table II , these five strains showed marked strain-related differences in their susceptibility to the bactericidal action of normal human sera, but there was relatively less variation in the activity of the 20 sera against any individual strain. The bactericidal activity of male and female sera for these strains was similar, with geometric mean titers of 44.63 (female) and 45.25 (male) . No ABO blood groupassociated differences in bactericidal activity were found.
Eight strains of gonococci isolated from patients with the DGI syndrome were resistant (serum titer < 2) to each of the 20 sera tested (Table II) . Seven of these strains required arginine, hypoxanthine, and uracil for growth and one was prototrophic.
The susceptibility of eight anogenital isolates to the complement-dependent bactericidal activity of pooled normal human sera was determined after 1 and 10 selective passages in vitro as Ti or T2 colonies on synthetic medium (Table III) . A fourfold change in titer occurred in only one instance (strain 6).
Kinetics of the bactericidal action of pooled normal human sera on isolates from urethral, cervical, and disseminated infections. The bactericidal reaction in pooled sera that had been stored at -70°C to preserve complement was characterized for strains isolated from disseminated infections by a variable lag period (22-60 min) during which the CFU count did not change, followed by the onset of killing (Fig. 1) . Strain F62, an urethral isolate, was killed within 2 min without a detectable initial delay. Strain 2017, isolated from blood, and strain 1947, isolated from a joint effusion were only partially killed (30 and 4%, respectively) at the end ofthe 90-min reaction (Fig. 1) .
All isolates from patients with disseminated infections tested in the kinetic study had been shown to be serum resistant (bactericidal titer < 2) in the stand- ard bactericidal assav (Table II) which was conducted for a 60-min reactioni period and in which the lowest testable titer was one part serum diluted by two parts bacterial suspension and complement added to achieve a final activity of >20 CH50 U/ml. Two of four of these serum-resistant strains (1939 and 1349) were observed to be killed in the kinetic studies (99% reduction in CFU) by the end of a 70-min reaction period (Fig. 1) in the reaction mixture containing 1 part bacterial suspension to 10 parts serum (containing both antibody and complement) to more closely approximate in vivo conditions. The onset of killing occurred later for isolates from disseminated infections than for those from uncomplicated genital infections, but differences in the rate of killing thereafter were less marked. An association was observed between bactericidal titers and killing kinetics. Those strains killed by the highest titers of normal sera had the earliest onset of killing in kinetic experiments.
Relationship of auxotype, penicillin and serum susceptibility, and syndrome. 36 of39 strains isolated from cases of DGI in Seattle required arginine, hypoxanthine, and uracil for growth (Arg-Hyx-Ura-auxotype) and were susceptible to c0.030 ug/ml of penicillin G (Table I ). All of these 36 Arg-Hyx-Urastrains (100%) were resistant to the bactericidal action of pooled or individual normal human sera (Table  IV) . 3 of 39 isolates from Seattle patients with DGI were not of the Arg-Hyx-Ura-auxotype and were resistant to 0.030 pLg/ml of penicillin G (Table I ).
All three were tested in the bactericidal assay (Table  IV) . Two of these were serum resistant, but one was killed at a titer of 2,048. This was a proline requiring cervical isolate from a patient with chronic arthritis, positive latex fixation test for rheumatoid factor (titer = 1: 160), and hyperglobulinemia (serum globulin = 5.5 g/100 ml). Therefore, serum-resistant isolates from Seattle patients with DGI were present in 38 of 39 (97%) cases of disseminated disease. 43 cervical or urethral isolates from patients with uncomplicated gonorrhea were also tested in the bactericidal assay against individual or pooled normnal human sera (Tables I and V) . 12 of these were Arg-Hyx-Ura-strains, susceptible to .0.030 gg/ml of penicillin G, and all were serum resistant (bactericidal titer < 2). The remaining 31 isolates did not require arginine, hypoxanthine, and uracil for growth, and 13 of these 31 strains (41.9%) were serum resistant (X2= 9.22, P < 0.005). Exclusive of Arg-Hyx-Urastrains, serum resistance, penicillin MIC, and auxotype were not uniquely associated. In contrast, all Arg-Hyx-Ura-strains tested (Tables IV and V) , whether from patients with uncomplicated gonorrhea (12 (16) , have produced experimental urethritis in man (17) and chimpanzees (26) (27) (28) , and are infective for the chick embryo (29, 30) . In addition, they have been reported to be more resistant in an in vitro complement-dependent bactericidal assay than colony vari- t Positive culture from blood or skin pustule on day acute serum was obtained.
ants T3 or T4 (31) . Organisms were harvested in early log phase for use in the bactericidal assay since the rate of killing may be influenced by the bacterial growth phase (32, 33) . The number of organisms in the reaction mixture was kept small (-5 x 103 CFU/ ml) to minimize clumping during the assay, and the effect of clumping was controlled for by calculating percent survivors from a heat-inactivated serum control. Unabsorbed serum from a patient with X-linked agammaglobulinemia was used as the complement source because other complement sources are bactericidal for some gonococci and require absorption of bactericidal antibodies with gonococci. This process may result in the retention of soluble bacterial antigens that could inhibit the bactericidal reaction. Only one of four serum-resistant strains maintained as colony variants Ti or T2 became more serum sensitive after 10 in vitro passes in the present study. However, Ward et al. (34) , in a bactericidal assay uncontrolled for bacterial growth phase or colony type, found that gonococci in urethral exudates or grown on prostatic extract media (35) were serum resistant and that some became sensitive when retested after subculture on Kellogg's media.
Normal human sera from different donors tested against individual strains ofserum-sensitive or resistant gonococci resulted in similar bactericidal titers (Table   II) . Though Abdoosh (36) was unable to demonstrate the presence of bactericidal antibody from normal human sera for three strains of gonococci, this study showed that most individuals without a history of gonorrhea appear to possess bactericidal antibodies against many gonococci isolated from uncomplicated infections. The origin of these naturally occurring bactericidal antibodies is unknown. It is unlikely that they arise as a result ofprior infection with, or asymptomatic carriage of, the homologous species, although it has been shown that "natural" meningococcal antibodies can occur in this fashion (37, 38) . It is possible they derive from the presence of crossreactive antigens shared with meningococci (10, 39) or with nonpathogenic Neisseria present as respiratory tract commensals (36), or with enteric bacteria in a relationship analogous to the immunochemical similarity which exists between antigens of some species of Escherichia coli and the capsular polysaccharides of N. meningitidis, Haemophilus influenzae type B, and Streptococcus pneumoniae (40) (41) (42) (43) (44) .
No sex-related differences in the bactericidal action of normal human sera were observed, although recent studies have shown DGI to be more common in women than in men (1) . No relationship between blood type and the bactericidal power of sera was noted in this survey of serum from 20 normal donors, though blood group antigens have been shown to cross react with those of some gram-negative organisms (45, 46) and an association between blood group and infections caused by enteric bacilli has been shown in several studies (47) .
Significant differences were noted in the susceptibility of serum-sensitive strains to the bactericidal action of normal human sera (Table II) . This was reflected in both the bactericidal titer and rate of killing of individual isolates such that a spectrum of serum susceptibility emerged as a continuum from nearly resistant to extreme sensitivity.
With a single exception, all strains isolated from patients with DGI were resistant to the bactericidal action of individual or pooled normal human sera from 20 male and female donors without a history of gonorrhea (Table IV) . Spink and Keefer (11, 48) examined the complement-dependenit bactericidal activity of whole defibrinated blood from uninfected normal controls and from individuals with localized or systemic gonococcal infections. In a standardized bactericidal assay, they noted that undiluted defibrinated blood from uninfected controls was able to kill . 100 organisms from an unspecified inoculum for 7 of 16 isolates from individual patients with urethritis compared with 3 of 13 isolates from individual patients with gonococcal urethritis ( x2 = 0.60, P > 0.10). Although these differences did not achieve statistical significance, they postulated that the bactericidal activity of blood from normal individuals tended to be reduced for isolates from patients with systemic gonococcal infection, thereby predisposing to tissue invasion by these strains. They did not determine the titer of bactericidal antibody to systemic isolates in normal human serum, and their studies subsequently received little attention.
The mechanism for the observed variation in seiLim susceptibility of the strains studied here is uniknowni. Ward (10) found that the antigens involved in the normal serum bactericidal reaction were resistant to heat and trypsin, and concluded that these antigens were lipopolysaccharides. Our own unpublished studies confirmii their findings. Finially, it is possible that nonbactericidal antibody of the IgA class may compete for specific anitigenic sites on serum-resistaint strains, thereby inhibiting the action of bactericidal antibody (50) .
A relationship between viirulence anid resistanice to bactericidal antibody has been previously demiionistrated for other gram-negative organisms (5, 6 ). Roantree and Rantz (7) These studies suggest that the bactericidal activity of serum may prevent the systemilic inlvasionl an(dI survival of bacteria which are sertumii sensitive.
The bactericidal activity of normial sertumii for giaiminegative organiisms is complemenit depenidenit (6) and individuals with a deficiency or abnorm-ality of certain complemiienit comiiponienits have anl increased susceptibility to bacterial infectionis. In those witlh altered or diminished C3 or C5 activity, opsonlizaItion as well as bactericidal activity mnay vbe imlpaired (51) (52) (53) (54) (55) , and suisceptibility to graml-niegative bacteria appears to be increased. Of particular interest is the observation that C6-and C8-deficient patients appear uniquely susceptible to bacteremic gonococcal or' mileninigococcaI] inf'ectionls (56) (57) (58) , but 11sually%, lnot to othier-bacterial inifectionls. These individuals possessed normal complement-depenidenit chemiiotaxis aind opsonization, but lacked bactericidal activitv for N. goniorrhloeae in onie instanice (57) anid for Saohiwtella typhi anid H. inifltiewuzae, type B in aniiotlher (56 The bactericidal activity of acuite anid conivalescenit sera from patienits with DGI was equial or suiperior to that of pooled niormial humtaniiii sera for two strainis of serum-sensitive gonococci isolated from patients with uncomplicated gonorrhea (Table VI) . It is therefore significant that patients with DGI do not appear to differ from those with localized gonococcal infections with regard to possession of bactericidal serum antibody to N. gonorrhoeae.
In contrast, disseminated N. meiitigitidis infection is also associated with the absence of bactericidal serum antibodies for epidemic strains, but the absence of bactericidal antibody is thought to be an unusual occurrence limited to a minority of adults. Goldschneider et al. found during a localized outbreak of meningococcal disease that individuals possessing bactericidal antibodies to the epidemic strain frequently became colonized by the organism, but rarely developed clinical disease (38) .
Acute and convalescent sera from four of six patients with DGI were not bactericidal for the homologous infecting strain (Table VI) . Two patients with DGI possessed bactericidal antibody for their strains and the bactericidal activity of the convalescent sera was enhanced for each by twofold compared to the acute sera. Spink and Keefer (11) observed an increase in bactericidal activity for some patients during the course of gonococcal arthritis, but their report did not indicate the proportion of patients showing such a rise. Buchanan et al. (59) found that each of seven patients with DGI showed high antibody levels or a rise in serum antibody to gonococcal pili, and Hess et al. (60) , with an indirect fluorescent antibody method, noted antibody to gonococci in 100% of sera obtained [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] days after the onset of gonococcal arthritis. The absence of detectable bactericidal activity to the homologous strain in the convalescent sera of four of six patients in the present study is unexplained. This could be due to early treatmenit in this group of patients. Alternatively, the antigens involved in the bactericidal reactioni may be less immunogenic than pili antigens or those antigens mediating immunofluorescence, or the sensitivity of the bactericidal reaction may be less than that of other tests for antibody to gonococci which cause DGI.
Although bacteremia was not observed in the presence of bactericidal antibody by Keefer and Spink (61) , acute sera from two DGI patients in the present study were bactericidal in low titer for the homologous strain at the time of positive blood cultures. If the occurrence of gonococcemia can be confirmed in a larger number of patients whose serum is bactericidal, this would suggest that bactericidal antibody and complement alone do not prevent gon-ococcal bacteremia.
The fact that host factors other thani bactericidal antibody may also be important in the pathogenesis of DGI is apparent from the following analysis. Strains requiring arginine, hypoxanthine, and uracil for growth were susceptible to .0.030 Ag of penicillin G/ml and accounted for 98% of DGI and 38% of uncomplicated gonococcal infections in Seattle during 1971-1974 (3) . 36 such isolates from patients with DGI were serum resistant (Table IV) , as were each of 12 such isolates from patients with uncomplicated gonorrhea (Table V) . If the estimate is accurate that 1-3% of Seattle patients with gonorrhea develop DGI (1), it follows that only about 3-8% of individuals infected with Arg-Hyx-Ura-serum-resistant strains develop systemic disease. Menstruation and pharyngeal infection are host factors which appear to favor the dissemination of serum-resistant strains (1, 2) ; however the host factors which prevent their dissemination are largely unknown.
Virulence factor(s) other than resistance to the bactericidal action of normal human sera appear to be important in the pathogenesis of DGI. Strain-s not requiring arginine, hypoxanthine, and uracil were isolated from approximately 62% of patients with uncomplicated gonorrhea in Seattle during 1971-1974 (3) . In the present study, 13 of 31 (41.9%) of such strains were serum resistant (Table V) . Thus, serum-resistant strains not requiring argininie, hypoxanthine, and uracil accounted for an estimated 41 .9 x 62 = 26% of isolates from uncomplicated infections, but only 2% of strains causing DGI. Serumresistant strains which require argininie, hypoxan-thine, and uracil, may thus possess virulence factor(s) niot present in serum-resistant strains with other auxotrophic requirements. These factor(s) are at present unknown and it is not clear whether they are linked to the Arg-Hyx-Ura-phenotype or are coincidentally associated in a clone of gonococci which is particularly common in Seattle. Similarly, the conicurrenice of the Arg-Hyx-Ura-auxotype, penicillin sensitivity, serum resistance, and the association with DGI has thus far onily been documented for Seattle isolates. It is not knowni if it exists for strains from other geographic areas.
In conclusion, this study has established the signiificance of gonococcal resistanice to the bactericidal actioni of normiial humani serum in the pathogenesis of DGI. However, serum resistance must be regarded as a necessary but not a sufficient conidition for disseminliiation in patients with normial complement activity, both with respect to host factors (which may either favor or prevent dissemiiinationi of serumil-resistanit strainis), anid to virulence factor(s) other thani senrumi resistanice. The phenotypic associationi of the Arg--Hyx-Ura-auxotype, penicillin sensitivity, seruml resistance, and capacity to cause DGI has been doctumented for Seattle isolates anid its possible epidemiologic, genietic, anid physiologic bases and the immunochemical substrate of serum resistance remain intriguing problems requiring further study.
